A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors

Mojun Zhu, Julian R. Molina, Grace K. Dy, Gary A. Croghan, Yingwei Qi, James Glockner, Lorelei J. Hanson, Michelle M. Roos, Angelina D. Tan, Alex A. Adjei

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences